215
Views
8
CrossRef citations to date
0
Altmetric
Research Article

A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies

, , , , , , , & show all
Pages 2739-2747 | Received 14 Sep 2013, Accepted 07 Feb 2014, Published online: 20 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (7)

James M. Griffin, Fiona M. Healy, Lekh N. Dahal, Yngvar Floisand & John F. Woolley. (2022) Worked to the bone: antibody-based conditioning as the future of transplant biology. Journal of Hematology & Oncology 15:1.
Crossref
Richard J. Lin, Caleb Ho, Sean M. Devlin, Josel D. Ruiz, Molly A. Maloy, Gunjan L. Shah, Miguel-Angel Perales, Parastoo B. Dahi, Sergio A. Giralt, Michael Scordo, Heiko Schöder, Paul A. Hamlin, Allison M. Sigler, Ahmet Dogan & Craig S. Sauter. (2020) Impact of allogeneic hematopoietic cell transplantation on immune evasive mechanisms in relapsed refractory large B-cell lymphoma. Bone Marrow Transplantation 55:12, pages 2331-2334.
Crossref
Lily Yan & Alison Gulbis. 2019. Hematopoietic Cell Transplantation for Malignant Conditions. Hematopoietic Cell Transplantation for Malignant Conditions 37 57 .
Holger Dau, Philipp Kurz & Marc-Denis WeitzeKayane Mheidly, Roch Houot, Michael Scordo & Craig Moskowitz. 2019. Künstliche Photosynthese. Künstliche Photosynthese 157 166 .
Richard J. Lin, Caleb Ho, Patrick D. Hilden, Juliet N. Barker, Sergio A. Giralt, Paul A. Hamlin, Ann A. Jakubowski, Hugo R. Castro‐Malaspina, Kevin S. Robinson, Esperanza B. Papadopoulos, Miguel‐Angel Perales & Craig S. Sauter. (2018) Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP 53 alterations . British Journal of Haematology.
Crossref
A Mussetti, S M Devlin, H R Castro-Malaspina, J N Barker, S A Giralt, A D Zelenetz, C S Sauter & M-A Perales. (2015) Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab era. Bone Marrow Transplantation 50:10, pages 1293-1298.
Crossref
A-K Zoellner, S Fritsch, D Prevalsek, N Engel, M Hubmann, R Reibke, C T Rieger, J C Hellmuth, M Haas, F Mumm, T Herold, G Ledderose, W Hiddemann, M Dreyling, A Hausmann & J Tischer. (2015) Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma. Bone Marrow Transplantation 50:5, pages 679-684.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.